Aptevo Therapeutics Inc (NASDAQ:APVO) currently has a daily average trading volume of 5.71M but it saw 9006170 shares traded in last market. With a market cap of 2.59M USD, the company’s current market price of $0.28 came falling about -22.14 while comparing to the previous closing price of $0.35. In past 52 weeks, the stock remained buoying in the range of price level as high as $15.31 and as low as $0.14. In the recent trading on the day, stock has struck highest price mark of $0.253 while lowest mark touched by it was $0.32.
Taking a look at 20-day trading activity of Aptevo Therapeutics Inc (APVO) gives us an average price of $0.1820, while its current price level is -98.20% below from 52-week high level whereas it is 99.49% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.2682 while that of 200 days or SMA-200 reads an average of $2.2082. A closer look into the stock’s movement over the week reveals that its volatility is standing at 53.10% during that period while stretching the period over a month that decreases to 19.09%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 59.04 which implies that the stock is in neutral territory.
Over the week, APVO’s stock price is moving 77.38% up while it is 58.67% when we observe its performance for the past one month. Year-to-date it is -96.54% down and over the past year, the stock is showing a downside performance of -98.09%.
The latest quarterly earnings report issued by the company reported quarterly earnings per share (EPS) of -22 beat the consensus estimate of -33 for the same. The company is expected to be releasing its next quarterly report on 2024-Nov-12, for which analysts forecasted an EPS of -3.35 while estimate for next year EPS is -17.23.
Currently, Aptevo Therapeutics Inc’s total number of outstanding shares is 9.42M with 0.04% of that held by the insiders while 14.61% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -263.01% and return on equity (ROE) at -243.74%. Stock’s beta reads 5.13. Stock has a price to book (P/B) ratio of 0.25. Its return on asset (ROA) is -115.20% on average.
